Lupin

Sumita Mohapatro Pani, Vice President & Head, Atharv Ability in an interaction with Kalyani Sharma talks about the rising…

Asthma education plays a vital role in empowering patients to make informed decisions and lead healthier lives. It is equally…

Humrahi empowers patients with the knowledge and skills necessary for precise insulin injection techniques

First-ever product launch in the inhalation segment in Germany

Collaboration to enhance healthcare services, ensure timely diagnosis, and improve accessibility of healthcare services

It is currently available in 10 cities and can be availed by patients by reaching out to their consulting cardiologists

Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and…

Clinical data suggests that it is effective on patients with co-morbidities

Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…

The platform is the latest initiative under Lupin’s long-running umbrella programme, Joint Airways Initiative (JAI), for patients…